Intellia Therapeutics Inc (NTLA)

Finanzdaten der Intellia Therapeutics Inc-Aktie (NTLA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	49.10%7.66	15.05	23.02	13.78	14.25
	2.30%82.60	80.74	-	-	-
Research and Development	2.30%82.60	80.74	-	-	-
Costs And Expenses	4.19%120.42	115.58	121.73	125.26	124.24
Operating Income/Loss	12.16%-112.76	-100.53	-98.71	-111.48	-110.00
	10.81%-106.63	-96.23	-95.79	-101.32	-101.26
Attributable To Parent	10.81%-106.63	-96.23	-95.79	-101.32	-101.26
Basic Average Shares	12.65%133.48	118.49	2.54	110.19	103.73
Diluted Average Shares	12.65%133.48	118.49	2.54	110.19	103.73
Basic Earnings Per Share	1.23%-0.80	-0.81	-0.82	-0.92	-0.98
Diluted Earnings Per Share	1.23%-0.80	-0.81	-0.82	-0.92	-0.98